SCHEMBL29627249

SCHEMBL29627249

C[Si](C)(C)CCOCn1cc(-c2cccc(C(N)=O)c2)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.47
FYN P06241 4/20 0.40
FLT1 P17948 2/20 0.40
VEGFA P15692 1/20 0.40
EGLN1 Q9GZT9 1/20 0.40
NR4A2 P43354 1/20 0.38
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
ERN1 O75460 1/20 0.38
TRPV1 Q8NER1 2/20 0.37
MGLL Q99685 1/20 0.37
CCNT1 O60563 1/20 0.37
CCND1 P24385 1/20 0.37
CCNC P24863 1/20 0.37
CDK8 P49336 1/20 0.37
CDK7 P50613 1/20 0.37
CDK9 P50750 1/20 0.37
CCNH P51946 1/20 0.37
MNAT1 P51948 1/20 0.37
CDK6 Q00534 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29627217 0.90 LMNA (0.41) NPC1EGLN1
SCHEMBL23193787 0.90 LMNA (0.41) NPC1EGLN1
SCHEMBL28753153 0.88 GABRG2 (0.43) ERN1MGLLCDK8
SCHEMBL31173835 0.87 MAPKAPK2 (0.47) NPC1MKNK1MKNK2CCNCCDK8
SCHEMBL3698405 0.82 NPC1 (0.46) NPC1MKNK1MKNK2KLKB1MAPKAPK2
SCHEMBL19398641 0.81 TEK (0.41) TGFBR1
SCHEMBL13283615 0.80 KCNH2 (0.51) NPC1
SCHEMBL30615628 0.80 KCNH2 (0.51) NPC1
SCHEMBL29627237 0.80 NPC1 (0.49) NPC1FYNFLT1VEGFAEGLN1
SCHEMBL23164504 0.79 L3MBTL1 (0.40) NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114466844-B N- (1H-imidazol-2-yl) benzamide compound and pharmaceutical composition comprising same as active ingredient 康佳诺医疗科技发展有限公司 2025-02-18 CN disclosed
CN-114466844-A N- (1H-imidazol-2-yl) benzamide compounds and pharmaceutical compositions containing the same as active ingredient 康佳诺医疗科技发展有限公司 2022-05-10 CN disclosed